Navigation Links
BUSM researchers find no adjustment method fully resolves confounding by indication
Date:5/26/2009

(Boston) - Researchers at Boston University School of Medicine (BUSM) and Boston University School of Public Health have found that no adjustment method fully resolves confounding by indication in observational studies, meaning when the validity of a study is threatened by unmeasured confounding, it is not straightforward to determine which method of adjustment, if any, is most effective in obtaining a valid and precise estimate of effect. The study appears online in the Journal of Clinical Epidemiology.

According to researchers, conventional methods to adjust for confounding, such as restriction and multivariable regression, leave residual confounding because of unmeasured factors. Propensity scores (PS) and instrumental variable (IV) methods have become increasingly popular with the intent to address residual confounding by simulating a randomized environment.

Using data from the Breast Cancer Effectiveness in Older Women study, a collaboration of investigators from the National Cancer Institute-funded Cancer Research Network, the researchers compared methods used to reduce confounding to estimate incidence rates of breast cancer recurrence in older women who received adjuvant chemotherapy compared with women who did not.

The researchers examined women 65 years of age or older diagnosed with early stage breast cancer. For women classified as high risk for recurrence, 20 percent experienced a breast cancer recurrence. In the unrestricted cohort, receipt of adjuvant chemotherapy was associated with recurrence. The PS distributions among women who received chemotherapy among those who did not showed no substantial overlap. Using the IV method, recurrence yielded a protective estimate. However, imbalances of measured factors across levels of the IV suggested residual confounding.

"With minimal trial-based information available to inform clinical guidelines, which currently offer no guidance for treating older women with cancer, non-randomized studies are vitally important," said lead author Jaclyn Bosco, MPH, project director in the Section of Geriatrics at BUSM. "Non-randomized studies are only reliable when confounding by indication is handled adequately. When treatment with adjuvant chemotherapy among older patients is based on clinical judgment, controlling for prognostic factors alone leaves residual confounding by indication."

Researchers further stated that PS and IV analysis methods can be useful under specific situations, but neither method adequately controlled confounding by indication in this study.


'/>"/>

Contact: Michelle Roberts
michelle.roberts@bmc.org
617-638-8491
Boston University Medical Center
Source:Eurekalert

Related medicine news :

1. Researchers gain ground in efforts to fight parasite infection
2. Poor attention in kindergarten predicts lower high school test scores, UC Davis researchers find
3. NYU School of Medicine pathology researchers solve another mystery in B lymphocyte development
4. Mayo Clinic Researchers Examine the Psychological Impact of Child Abuse
5. Mayo Clinic researchers examine the psychological impact of child abuse
6. CSI: Mayo Clinic Researchers Find Television Shows Inaccurately Portray Violent Crime
7. Mayo Clinic Researchers Say Triple Drug Combination is Promising Option to Treat Metastatic HER2+ Breast Cancer
8. Two Targeted Therapies Likely Better Than One in Patients with Aggressive Lymphoma, Mayo Clinic Researchers Say
9. Mayo Clinic Researchers Say Agent Provides Treatment Option for Women with Hot Flashes
10. Drug That Targets Vasculature Growth Attacks Aggressive Thyroid Cancer, Mayo Clinic Researchers Report
11. BUSM researchers find gram-negative rods in two Philippine neonatal intensive care units
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... June 26, 2016 , ... On June 10-11, 2016, A Forever Recovery, ... Festival and World’s Longest Breakfast Table in Battle Creek, MI, where the rehabilitation facility ... home to some of the world’s leading providers of cereal and other breakfast foods. ...
(Date:6/26/2016)... ... June 26, 2016 , ... Many women are confused ... endometriosis. These women need a treatment plan to not only alleviate symptoms and ... help for preservation of fertility and ultimately achieving a pregnancy. The specialists at ...
(Date:6/25/2016)... ... 2016 , ... "With 30 hand-drawn hand gesture animations, FCPX users can easily ... of Pixel Film Studios. , ProHand Cartoon’s package transforms over 1,300 hand-drawn pictures ... . Simply select a ProHand generator and drag it above media or text in ...
(Date:6/25/2016)... ... 2016 , ... On Friday, June 10, Van Mitchell, Secretary of the Maryland ... iHire in recognition of their exemplary accomplishments in worksite health promotion. , The Wellness ... & Wellness Symposium at the BWI Marriott in Linthicum Heights. iHire was one of ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World ... with chronic pain and the benefits of holistic treatments, Serenity Recovery Center ... with Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... a startling report released today, National Safety Council research ... proven plan to eliminate prescription opioid overdoses. Prescription Nation ... tackling the worst drug crisis in recorded U.S. history, assigned a ... , New Mexico , Tennessee ... failing states, three – Michigan , ...
(Date:6/23/2016)... 2016 Capricor Therapeutics, Inc. ... biotechnology company focused on the discovery, development and ... enrollment in its ongoing randomized HOPE-Duchenne clinical trial ... of its 24-patient target. Capricor expects the trial ... of 2016, and to report top line data ...
(Date:6/23/2016)... MOUNTAIN VIEW, Calif. , June 23, 2016 ... 9:00 a.m. CST on Thursday, July 7, 2016 , , ... kayla.belcher@frost.com ) , , , , EXPERT PANELISTS:  ... Sciences, Nitin Naik; Senior Industry Analyst, Christi Bird; Senior Industry Analyst, ... The global pharmaceutical industry is witnessing ...
Breaking Medicine Technology: